Determinants of anti-retroviral regimen changes among HIV/AIDS patients of east and west Wollega zone health institutions, Oromia region, west Ethiopia: a cross-sectional study.

CONCLUSIONS: The number of patients who changed ARV drug in our resource constrained setting present a challenge to the restricted treatment choices that we currently own. Less toxic and better-tolerated HIV treatment options should be available and used more frequently. PMID: 29871665 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/29871665?dopt=Abstract

Source: BMC Pharmacology and Toxicology - June 7, 2018 Category: Drugs & Pharmacology Tags: BMC Pharmacol Toxicol Source Type: research